Publications

Publications

Publications 
  1. Nicorandil-Induced Colovesical Fistula in a Patient with Diverticular Disease, 2021 https://doi.org/10.1002/ccr3.3888
  2. Baxter, M.A., Middleton, F., Cagney, H.P. et al. Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers. Br J Cancer (2021). https://doi.org/10.1038/s41416-021-01425-7
  3. Noyes, J. D., Mordi, I. R., Zeb, Q. & Lang, C. C., Mar 2021, In: Clinical Case Reports. 9, 3, p. 1737-1741 5 p. 
  4. Genetic Risk of Diverticular Disease Predicts Early Stoppage of Nicorandil, 2021 doi:10.1002/cpt.1941
  5. Noyes, J., Mordi, I. R., Doney, A. S., Palmer, C. N. A., Pearson, E. R. & Lang, C. C., Dec 2020, In: Clinical Pharmacology and Therapeutics. 108, 6, p. 1171-1175 5 p. 
  6. High response and reinfection rate among people who inject drugs treated for hepatitis C in community needle and syringe programme. Jasmine Schulkind, Brian Stephens, Farsana Ahmad, Linda Johnston; Sharon Hutchinson, Donna Thain, Zoe Ward, Peter Vickerman, Matthew Hickman, John Dillon. Journal of Viral Hepatitis. 2019 May;26(5):519-528. https://doi.org/10.1111/jvh.13035 
  7. The Addition of Vitamin D Supplementation to Interferon and Ribavirin in the Treatment of Hepatitis C Virus Infection: A Randomised Double-Blind Placebo-Controlled Pilot Study. Josh T Coats, Adrian Hapca, Miles D Witham, Peter T. Donnan, Mathis Heydtmann, Andrew Bathgate, Peter C Hayes, Andrew Fraser, Morgan Evans, Clifford Leen, Peter Bramley, Stephen T. Barclay, Raymond Fox, John F Dillon Archives of Gastroenterology and Hepatology. 2018; 1:39-48 
  8. Iain Swan, Zi Yi Tew, John F Dillon, Rami J Abboud. Electrostimulation of Muscles Mimics the Effect of Physical Exercise on Non-alcoholic Fatty Liver Disease: A Systematic Review. AASCIT Journal of Medicine. Vol. 3, No. 1, 2017, pp. 1-9.
  9. Treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.  J D Leask, J F Dillon,. Alimentary pharmacology & therapeutics 2016: 44; 145-156.
  10. Cathcart J, Cowan N, Tully V. Referral Finder: Saving Time and Improving The Quality of In-hospital Referrals. BMJ Quality Improvement Reports 2016;5(1) doi:10.1136/bmjquality.u209356.w3951 
  11. Ross D, Petrie C, Tully V. Introduction of a junior doctors' handbook: an essential guide for new doctors. BMJ Quality Improvement Reports 2016;5(1) doi: 10.1136/bmjquality.u209167.w3822
  12. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations. A systematic review of the literature. JT Coates, John F Dillon.  International Journal of Drug Policy 2015; 06/2015; DOI:10.1016/j.drugpo.2015.05.001 
  13. Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease" Kayleigh L Wood, Michael H Miller and John F Dillon. BMJ Open Gastroenterology 2015;2:e000019. doi:10.1136/bmjgast-2014-000019
  14. M Anwar, MH Miller, JF Dillon. Systematic review of association of serum bilirubin levels and non-alcoholic fatty liver disease: a feasible therapeutic avenue? World Journal of Pharmacology 2014;3: 209-216.  
  15. "Lifestyle interventions for the treatment of non-alcoholic fatty liver disease" V Bradford, JF Dillon, MH Miller. Hepatic Medicine: Evidence and Research 2014;6:1–10. 
  16. Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data. J Kevin Dunbar, John Dillon, O James Garden, David H Brewster. HPB 2013;15:279-285.
  17. Hasnain Jafferbhoy, M H Miller, EB Henry, W Gashau, C Chandra Shekar, M Lockhart, J F Dillon Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infection. GUT 2012;61:1644-45. IF 10.614 (3/66) 
  18. H. Jafferbhoy, M.H. Miller, Z. El Wahed, J.F. Dillon. Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR. Journal of Hepatology 2011; 55: 1162–1167. IF6.62 (4/66)